These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10197265)

  • 1. Three different chromogenic methods do not give equivalent anti-Xa levels for patients on therapeutic low molecular weight heparin (dalteparin) or unfractionated heparin.
    Kovacs MJ; Keeney M; MacKinnon K; Boyle E
    Clin Lab Haematol; 1999 Feb; 21(1):55-60. PubMed ID: 10197265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti Xa monitoring during treatment with low molecular weight heparin or danaparoid: inter-assay variability.
    Kitchen S; Iampietro R; Woolley AM; Preston FE
    Thromb Haemost; 1999 Oct; 82(4):1289-93. PubMed ID: 10544915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of patient weight on the anticoagulant response to adjusted therapeutic dosage of low-molecular- weight heparin for the treatment of venous thromboembolism.
    Wilson SJ; Wilbur K; Burton E; Anderson DR
    Haemostasis; 2001; 31(1):42-8. PubMed ID: 11408748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-thrombotic efficacies of enoxaparin, dalteparin, and unfractionated heparin in venous thrombo-embolism.
    Morris TA; Marsh JJ; Konopka R; Pedersen CA; Chiles PG
    Thromb Res; 2000 Nov; 100(3):185-94. PubMed ID: 11108906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new chronometric assay to determine plasma antifactor Xa activity which is insensitive to the antithrombin activity of low molecular weight heparins.
    Dignac M; Gabaig AM; Cambus JP; Boneu B
    Nouv Rev Fr Hematol (1978); 1994; 35(6):545-9. PubMed ID: 8152901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring unfractionated heparin therapy: relationship between eight anti-Xa assays and a protamine titration assay.
    Kitchen S; Theaker J; Preston FE
    Blood Coagul Fibrinolysis; 2000 Mar; 11(2):137-44. PubMed ID: 10759006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Puerperal thromboprophylaxis: comparison of the anti-Xa activity of enoxaparin and unfractionated heparin.
    Gibson JL; Ekevall K; Walker I; Greer IA
    Br J Obstet Gynaecol; 1998 Jul; 105(7):795-7. PubMed ID: 9692422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 3.2 vs. 3.8% sodium citrate concentration on anti-Xa levels for patients on therapeutic low molecular weight heparin.
    Payne S; MacKinnon K; Keeney M; Morrow B; Kovacs MJ
    Clin Lab Haematol; 2003 Oct; 25(5):317-9. PubMed ID: 12974723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin-Calibrated Chromogenic Anti-Xa Activity Measurements in Patients Receiving Rivaroxaban: Can This Test Be Used to Quantify Drug Level?
    Gosselin RC; Francart SJ; Hawes EM; Moll S; Dager WE; Adcock DM
    Ann Pharmacother; 2015 Jul; 49(7):777-83. PubMed ID: 25855705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of three low-molecular weight heparins (LMWH) and unfractionated heparin (UH) in healthy volunteers.
    Eriksson BI; Söderberg K; Widlund L; Wandeli B; Tengborn L; Risberg B
    Thromb Haemost; 1995 Mar; 73(3):398-401. PubMed ID: 7667822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thromboprophylaxis following caesarean section--a comparison of the antithrombotic properties of three low molecular weight heparins--dalteparin, enoxaparin and tinzaparin.
    Ellison J; Thomson AJ; Conkie JA; McCall F; Walker D; Greer A
    Thromb Haemost; 2001 Dec; 86(6):1374-8. PubMed ID: 11776302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PiCT
    Brisset AC; Ferrández A; Krause M; Rathbun S; Marlar R; Korte W
    J Thromb Haemost; 2016 Nov; 14(11):2187-2193. PubMed ID: 27582411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of a dalteparin prophylaxis protocol using anti-factor Xa concentrations on venous thromboembolism in high-risk trauma patients.
    Droege ME; Mueller EW; Besl KM; Lemmink JA; Kramer EA; Athota KP; Droege CA; Ernst NE; Keegan SP; Lutomski DM; Hanseman DJ; Robinson BR
    J Trauma Acute Care Surg; 2014 Feb; 76(2):450-6. PubMed ID: 24458050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dalteparin dose-dependently increases ROTEM(®) thrombelastography parameters only at supratherapeutic anti-factor Xa levels: an in vitro study.
    Feuring M; Wehling M; Schultz A
    Clin Exp Pharmacol Physiol; 2011 Nov; 38(11):783-6. PubMed ID: 21883380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin and low molecular weight heparin: is anti-factor Xa activity important?
    Lane DA; Ryan K
    J Lab Clin Med; 1989 Oct; 114(4):331-3. PubMed ID: 2551984
    [No Abstract]   [Full Text] [Related]  

  • 16. Laboratory analysis of blood samples from patients treated with tinzaparin.
    Hoppensteadt DA; Willows L; Leitz H; Nicolaides A; Fareed J
    Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():49-55. PubMed ID: 15085466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Monitoring anticoagulation by fondaparinux: determination of anti factor Xa-level].
    Dämgen-von Brevern G; Kläffling C; Lindhoff-Last E
    Hamostaseologie; 2005 Aug; 25(3):281-5. PubMed ID: 16113752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-factor Xa determination in blood: a new method for controlling heparin therapy.
    Harenberg J; Haaf B; Schäfer M; Dempfle CE; Stehle G; Heene DL
    Semin Thromb Hemost; 1993; 19 Suppl 1():79-85. PubMed ID: 8395736
    [No Abstract]   [Full Text] [Related]  

  • 19. Dosage, anticoagulant, and antithrombotic effects of heparin and low-molecular-weight heparin in the treatment of deep vein thrombosis.
    Harenberg J; Stehle G; Blauth M; Huck K; Mall K; Heene DL
    Semin Thromb Hemost; 1997; 23(1):83-90. PubMed ID: 9156415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between anti-Xa and occurrence of thrombosis and haemorrhage in post-surgical patients treated with either Logiparin (LMWH) or unfractionated heparin. Post-surgery Logiparin Study Group.
    Bara L; Leizorovicz A; Picolet H; Samama M
    Thromb Res; 1992 Mar; 65(4-5):641-50. PubMed ID: 1319619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.